Industry: Service & Software
Published Date: 2025-02-21
Pages: 103 Pages
Report ld: 4146828
Request Sample
Customized Report
The global RNA-Seq market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
The global RNA-Seq market is experiencing rapid growth due to advancements in sequencing technologies, decreasing costs, and increasing demand for personalized medicine and genomics research. This market holds immense potential for further development and innovation, making it a focal point for companies and researchers in the life sciences industry.
The global RNA-Seq market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global RNA-Seq market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of RNA-Seq in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.
Chapter 3: Detailed analysis of RNA-Seq manufacturers competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Region analysis by company, by Type, by Application, revenue for each segment.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, RNA-Seq revenue, gross margin, and recent development, etc.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 sRNA-Seq
1.2.3 targeted RNA-Seq
1.2.4 long-read RNA-Seq
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Research Institutes
1.3.3 Hospitals & Clinics
1.3.4 Biotechnology Company
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNA-Seq Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global RNA-Seq Revenue Market Share by Region (2020-2025)
2.4 Global RNA-Seq Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America RNA-Seq Market Size and Prospective (2020-2031)
2.5.2 Europe RNA-Seq Market Size and Prospective (2020-2031)
2.5.3 China RNA-Seq Market Size and Prospective (2020-2031)
2.5.4 Japan RNA-Seq Market Size and Prospective (2020-2031)
2.5.5 Southeast Asia RNA-Seq Market Size and Prospective (2020-2031)
2.5.6 India RNA-Seq Market Size and Prospective (2020-2031)
2.5.7 Central & South America RNA-Seq Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global RNA-Seq Historic Market Size by Type (2020-2025)
3.2 Global RNA-Seq Forecasted Market Size by Type (2026-2031)
3.3 Different Types RNA-Seq Representative Players
4 Breakdown Data by Application
4.1 Global RNA-Seq Historic Market Size by Application (2020-2025)
4.2 Global RNA-Seq Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in RNA-Seq Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top RNA-Seq Players by Revenue (2020-2025)
5.1.2 Global RNA-Seq Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by RNA-Seq Revenue
5.4 Global RNA-Seq Market Concentration Analysis
5.4.1 Global RNA-Seq Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by RNA-Seq Revenue in 2024
5.5 Global Key Players of RNA-Seq Head office and Area Served
5.6 Global Key Players of RNA-Seq, Product and Application
5.7 Global Key Players of RNA-Seq, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America RNA-Seq Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America RNA-Seq Market Size by Type (2020-2025)
6.1.2.2 North America RNA-Seq Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America RNA-Seq Market Size by Application (2020-2025)
6.1.3.2 North America RNA-Seq Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe RNA-Seq Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe RNA-Seq Market Size by Type (2020-2025)
6.2.2.2 Europe RNA-Seq Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe RNA-Seq Market Size by Application (2020-2025)
6.2.3.2 Europe RNA-Seq Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China RNA-Seq Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China RNA-Seq Market Size by Type (2020-2025)
6.3.2.2 China RNA-Seq Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China RNA-Seq Market Size by Application (2020-2025)
6.3.3.2 China RNA-Seq Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan RNA-Seq Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan RNA-Seq Market Size by Type (2020-2025)
6.4.2.2 Japan RNA-Seq Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan RNA-Seq Market Size by Application (2020-2025)
6.4.3.2 Japan RNA-Seq Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 Southeast Asia Market: Players, Segments and Downstream
6.5.1 Southeast Asia RNA-Seq Revenue by Company (2020-2025)
6.5.2 Southeast Asia Market Size by Type
6.5.2.1 Southeast Asia RNA-Seq Market Size by Type (2020-2025)
6.5.2.2 Southeast Asia RNA-Seq Market Share by Type (2020-2025)
6.5.3 Southeast Asia Market Size by Application
6.5.3.1 Southeast Asia RNA-Seq Market Size by Application (2020-2025)
6.5.3.2 Southeast Asia RNA-Seq Market Share by Application (2020-2025)
6.5.4 Southeast Asia Market Trend and Opportunities
6.6 India Market: Players, Segments and Downstream
6.6.1 India RNA-Seq Revenue by Company (2020-2025)
6.6.2 India Market Size by Type
6.6.2.1 India RNA-Seq Market Size by Type (2020-2025)
6.6.2.2 India RNA-Seq Market Share by Type (2020-2025)
6.6.3 India Market Size by Application
6.6.3.1 India RNA-Seq Market Size by Application (2020-2025)
6.6.3.2 India RNA-Seq Market Share by Application (2020-2025)
6.6.4 India Market Trend and Opportunities
7 Key Players Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Company Details
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific RNA-Seq Introduction
7.1.4 Thermo Fisher Scientific Revenue in RNA-Seq Business (2020-2025)
7.1.5 Thermo Fisher Scientific Recent Development
7.2 Illumina
7.2.1 Illumina Company Details
7.2.2 Illumina Business Overview
7.2.3 Illumina RNA-Seq Introduction
7.2.4 Illumina Revenue in RNA-Seq Business (2020-2025)
7.2.5 Illumina Recent Development
7.3 BGI
7.3.1 BGI Company Details
7.3.2 BGI Business Overview
7.3.3 BGI RNA-Seq Introduction
7.3.4 BGI Revenue in RNA-Seq Business (2020-2025)
7.3.5 BGI Recent Development
7.4 PacBio
7.4.1 PacBio Company Details
7.4.2 PacBio Business Overview
7.4.3 PacBio RNA-Seq Introduction
7.4.4 PacBio Revenue in RNA-Seq Business (2020-2025)
7.4.5 PacBio Recent Development
7.5 Genewiz
7.5.1 Genewiz Company Details
7.5.2 Genewiz Business Overview
7.5.3 Genewiz RNA-Seq Introduction
7.5.4 Genewiz Revenue in RNA-Seq Business (2020-2025)
7.5.5 Genewiz Recent Development
7.6 Macrogen
7.6.1 Macrogen Company Details
7.6.2 Macrogen Business Overview
7.6.3 Macrogen RNA-Seq Introduction
7.6.4 Macrogen Revenue in RNA-Seq Business (2020-2025)
7.6.5 Macrogen Recent Development
7.7 LabCorp
7.7.1 LabCorp Company Details
7.7.2 LabCorp Business Overview
7.7.3 LabCorp RNA-Seq Introduction
7.7.4 LabCorp Revenue in RNA-Seq Business (2020-2025)
7.7.5 LabCorp Recent Development
7.8 Roche
7.8.1 Roche Company Details
7.8.2 Roche Business Overview
7.8.3 Roche RNA-Seq Introduction
7.8.4 Roche Revenue in RNA-Seq Business (2020-2025)
7.8.5 Roche Recent Development
7.9 Qiagen
7.9.1 Qiagen Company Details
7.9.2 Qiagen Business Overview
7.9.3 Qiagen RNA-Seq Introduction
7.9.4 Qiagen Revenue in RNA-Seq Business (2020-2025)
7.9.5 Qiagen Recent Development
7.10 Eurofins
7.10.1 Eurofins Company Details
7.10.2 Eurofins Business Overview
7.10.3 Eurofins RNA-Seq Introduction
7.10.4 Eurofins Revenue in RNA-Seq Business (2020-2025)
7.10.5 Eurofins Recent Development
7.11 Novo Gene
7.11.1 Novo Gene Company Details
7.11.2 Novo Gene Business Overview
7.11.3 Novo Gene RNA-Seq Introduction
7.11.4 Novo Gene Revenue in RNA-Seq Business (2020-2025)
7.11.5 Novo Gene Recent Development
7.12 Berry Genomics
7.12.1 Berry Genomics Company Details
7.12.2 Berry Genomics Business Overview
7.12.3 Berry Genomics RNA-Seq Introduction
7.12.4 Berry Genomics Revenue in RNA-Seq Business (2020-2025)
7.12.5 Berry Genomics Recent Development
7.13 LC Sciences
7.13.1 LC Sciences Company Details
7.13.2 LC Sciences Business Overview
7.13.3 LC Sciences RNA-Seq Introduction
7.13.4 LC Sciences Revenue in RNA-Seq Business (2020-2025)
7.13.5 LC Sciences Recent Development
7.14 Canopy Biosciences
7.14.1 Canopy Biosciences Company Details
7.14.2 Canopy Biosciences Business Overview
7.14.3 Canopy Biosciences RNA-Seq Introduction
7.14.4 Canopy Biosciences Revenue in RNA-Seq Business (2020-2025)
7.14.5 Canopy Biosciences Recent Development
7.15 Macrogen
7.15.1 Macrogen Company Details
7.15.2 Macrogen Business Overview
7.15.3 Macrogen RNA-Seq Introduction
7.15.4 Macrogen Revenue in RNA-Seq Business (2020-2025)
7.15.5 Macrogen Recent Development
7.16 Hologic
7.16.1 Hologic Company Details
7.16.2 Hologic Business Overview
7.16.3 Hologic RNA-Seq Introduction
7.16.4 Hologic Revenue in RNA-Seq Business (2020-2025)
7.16.5 Hologic Recent Development
8 RNA-Seq Market Dynamics
8.1 RNA-Seq Industry Trends
8.2 RNA-Seq Market Drivers
8.3 RNA-Seq Market Challenges
8.4 RNA-Seq Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for RNA-Seq was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-09
Pages: 129
USD 3950.00
(Single User License)
The global RNA-Seq market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 127
USD 2900.00
(Single User License)
The global RNA-Seq market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-01-10
Pages: 156
USD 4900.00
(Single User License)
The global RNA-Seq market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-25
Pages: 153
USD 4900.00
(Single User License)
The global market for RNA-Seq was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 140
USD 3950.00
(Single User License)
The global market for RNA-Seq was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-21
Pages: 99
USD 2900.00
(Single User License)
Market Analysis and Insights: Global RNA-Seq Market
Published Date: 2024-04-16
Pages: 119
USD 4900.00
(Single User License)
The global RNA-Seq market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-12
Pages: 99
USD 2900.00
(Single User License)
The global market for RNA-Seq was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-09
Pages: 129
The global RNA-Seq market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 127
The global RNA-Seq market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-01-10
Pages: 156
The global RNA-Seq market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-25
Pages: 153
The global market for RNA-Seq was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 140
The global market for RNA-Seq was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-21
Pages: 99
Market Analysis and Insights: Global RNA-Seq Market
Published: 2024-04-16
Pages: 119
The global RNA-Seq market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-12
Pages: 99
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now